Referred to the House Committee on Energy and Commerce.
This bill, the "Chloe Cole Act," would make it unlawful for health care professionals, hospitals, or clinics to participate in certain medical treatments for persons under 18 that the bill defines as "chemical or surgical mutilation." The prohibited practices include use of puberty blockers, cross-sex hormones, and surgical procedures intended to alter or remove sexual organs or change appearance to not correspond with an individual’s sex. The bill creates a federal civil cause of action allowing a child who was subjected to such treatment (or that child’s parents or guardians) to sue providers in federal court, authorizes compensatory, non-economic, and punitive damages, and imposes strict liability where participation after enactment is proven by clear and convincing evidence.
Whether the bill protects children (conservative view) versus whether it unlawfully eliminates access to medically accepted gender‑affirming care for minors and harms vulnerable youth (liberal view).
Relative to its intended legislative type, this bill establishes a clear substantive prohibition and private civil enforcement framework with many concrete elements (definitions, specified prohibited acts, exceptions, standards of proof, damages, and statute of limitations), but it leaves several operational and legal integration details under-specified.
This bill, the "Chloe Cole Act," would make it unlawful for health care professionals, hospitals, or clinics to participate in certain medical treatments for persons under 18 that the bill defines as "chemical or surgical mutilation." The prohibited practices include use of puberty blockers, cross-sex hormones, and surgical procedures intended to alter or remove sexual organs or change appearance to not correspond with an individual’s sex.
The bill creates a federal civil cause of action allowing a child who was subjected to such treatment (or that child’s parents or guardians) to sue providers in federal court, authorizes compensatory, non-economic, and punitive damages, and imposes strict liability where participation after enactment is proven by clear and convincing evidence.
Limited exceptions are carved out for verifiable disorders of sexual development, treatment of complications caused by prior interventions, other clearly medically necessary interventions for organ-system conditions, and detransition treatment; the bill also requires that exceptions be supported by clear and convincing evidence if asserted as a defense.
Judged solely on the bill text and historical legislative patterns, this proposal is unlikely to become law. It addresses a highly politicized topic, creates sweeping federal litigation exposure and strict liability for medical providers, and intrudes on areas traditionally regulated by states and medical boards. Those features typically provoke strong, organized opposition and constitutional or preemption challenges that reduce a bill's chances absent broad bipartisan compromise, which the text itself does not incorporate.
Relative to its intended legislative type, this bill establishes a clear substantive prohibition and private civil enforcement framework with many concrete elements (definitions, specified prohibited acts, exceptions, standards of proof, damages, and statute of limitations), but it leaves several operational and legal integration details under-specified.
Whether the bill protects children (conservative view) versus whether it unlawfully eliminates access to medically accepted gender‑affirming care for minors and harms vulnerable youth (liberal view).
These are examples from the analysis, not a ranked list of the most-affected groups.
Whether the bill protects children (conservative view) versus whether it unlawfully eliminates access to medically accepted gender‑affirming care for minors and harms vulnerable youth (liberal view).
A liberal/left-leaning observer would likely view this bill as a broad federal ban that effectively removes access to gender‑affirming medical care for minors and would see it as an intrusion into patient‑centered, evidence‑based medical decisionmaking.
They would note the bill’s wide definition of prohibited acts (puberty blockers, sex hormones, and surgeries) and the heavy civil exposure (strict liability, long statute of limitations, and treble-style damages including punitive damages possible).
They would be concerned about chilling effects on clinicians and mental‑health professionals who counsel or treat transgender youth, and about the bill reducing access to care that major medical associations sometimes recognize as appropriate in carefully selected cases.
A centrist/moderate would likely have a mixed reaction: seeing merit in protecting minors from irreversible procedures while worrying about the bill’s breadth, federalization, and litigation incentives.
They would appreciate the bill’s explicit exceptions for disorders of sexual development and for detransition care, but would flag the expansive definitions (especially the phraseology about intent to alter development) and the low tolerance for ambiguity (ambiguities resolved against defendants).
They would be concerned that strict liability and a long statute of limitations create very high legal and financial risks for providers and institutions, possibly disrupting care and leading to defensive medicine or refusal to treat.
A mainstream conservative observer would likely view the bill favorably as a protective measure to prevent minors from receiving what the sponsor characterizes as experimental or irreversible sex‑altering treatments.
They would emphasize parental authority and safeguarding children from interventions that change their reproductive anatomy or halt natural puberty.
The federal private right of action and the strict liability provisions would be seen as strong enforcement tools to hold providers and institutions accountable.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Judged solely on the bill text and historical legislative patterns, this proposal is unlikely to become law. It addresses a highly politicized topic, creates sweeping federal litigation exposure and strict liability for medical providers, and intrudes on areas traditionally regulated by states and medical boards. Those features typically provoke strong, organized opposition and constitutional or preemption challenges that reduce a bill's chances absent broad bipartisan compromise, which the text itself does not incorporate.
The bill has not accumulated any surfaced votes yet.
Whether the bill protects children (conservative view) versus whether it unlawfully eliminates access to medically accepted gender‑affirmin…
Judged solely on the bill text and historical legislative patterns, this proposal is unlikely to become law. It addresses a highly politici…
Relative to its intended legislative type, this bill establishes a clear substantive prohibition and private civil enforcement framework with many concrete elements (definitions, specified prohibited acts, exceptions, s…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.